期刊文献+

轻度认知障碍相关脑脊液标记物研究进展

下载PDF
导出
摘要 轻度认知障碍(MCI)是一种主要以认知功能减退为主要表现的疾病[1],其患者记忆力减退超出该段年龄的正常范围,尚达不到阿尔茨海默病的诊断标准[2-3]。轻度认知障碍据发病原因亦或是大脑损伤位置而异,可以累及记忆和执行功能、语言、运用及视觉空间结构技能等一项或多项,最终造成相应的临床病症发生。轻度认知障碍是介于正常老化与痴呆之间的一种认知缺损状态,近年来,
出处 《临床合理用药杂志》 2016年第5期178-179,共2页 Chinese Journal of Clinical Rational Drug Use
基金 河北省重大医学科研课题资助项目(No:2013067759)
  • 相关文献

参考文献17

  • 1Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment : clinical characterization and outcome [ J ]. Arch Neurol, 1999,56 (3) : 303 - 308.
  • 2Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status [ J ]. Lancet, 2010,355 ( 9199 ) : 225 - 228.
  • 3Petersen RC. Mild cognitive impairment:transition between aging and Alzheimerg disease [ J ]. Neurologia,2000,15(3 ) :93 - 101.
  • 4袁瑛,顾兆祥,魏文石,杨莉芹.脑显像对轻度认知障碍预后预测价值的Meta分析[J].中国神经精神疾病杂志,2011,37(2):92-96. 被引量:4
  • 5ShafferJL, Petrella JR, Sheldon FC, et al. Mild cognitive impairment cerebrospinal fluid biomarkers related research progress[ J]. Radiolo- gy,2013,86(266) :583.
  • 6Albert MSI, DeKosky ST, Dickson D. Mild cognitive impairment [ J ]. Alzheimers Dement,2011,39 (7) :270.
  • 7KaiserE, Schonkneeht P, Hunt A. et al. Mild cognitive impairment ce- rebrospinal fluid biomarkers related research progress [ J ]. ZCerontol Gefiatr,2008,91 (41) :497.
  • 8Philipp A, Thomann MD, Elmar Kaiser MD, et al. Association of total tau and phosphorylated tan 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer dis- ease [ J ]. Rev Psychiatr Neurosci ,2009,34 (2) :98 - 102.
  • 9Jack. CR Jr. knopman DS. Jagust WT, et. al. Hypothetical model of dynamic biomarkers of the Alzheimer's Pathological cascade[ J]. Lan- cet Neuro1,2010,9 ( 1 ) : 119 - 128.
  • 10Eider GA, Gama Sosa MA, De Gasperi R. Transgenic mouse models of Alzheimer's disease[ J]. Mount Sinai Journal of Medicine ,2010,2 (5) :196 -197.

二级参考文献24

  • 1Petersen RC,Stevens JC,Ganguli M,et al.Practice parameter:early detection of dementia-mild cognitive impairment (an evidence-based review).Report of the Quality Standards Subcommittee of the American Academy of Neurology[J].Neurology,2001,56(9):1133-1142.
  • 2McKhann G,Drachman D,Folstein M,et al.Clinical diagnosis of Alzheimer's disease:report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease[J].Neurology,1984,34(7):939-944.
  • 3American Psychiatric Association.American Psychiatric Association Committee on Nomenclature and Statistics.Diagnostic and Statistical Manual of Mental Disorders[M].4th ed.Washington,DC:American Psychiatric Press; 1994,143-147.
  • 4Chételat G,Desgranges B,de la Sayette V,et al.Mild cognitive impairment:can FDG-PET predict who is to rapidly convert to Alzheimer's disease?[J].Neurology,2003,60(8):1374-1377.
  • 5Anchisi D,Borroni B,Franceschi M,et al.Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease[J].Arch Neurol,2005,62(11):1728-1733.
  • 6Arnaiz E,Jelic V,Almkvist O,et al.Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment[J].Neuroreport,2001,12(4):851-855.
  • 7Mosconi L,Perani D,Sorbi S,et al.MCI conversion to dementia and the APOE genotype:a prediction study with FDG-PET[J].Neurology 2004,63(12):2332-2340.
  • 8Drzezga A,Grimmer T,Riemenschneider M,et al.Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET[J].J Nucl Med,2005,46(10):1625-1632.
  • 9Borroni B,Anchisi D,Paghera B,et al.Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD[J].Neurobiol Aging,2006,27(1):24-31.
  • 10Johnson KA,Jones K,Holman BL,et al.Preclinical prediction of Alzheimer's disease using SPECT[J].Neurology,1998,50(6):1563-1571.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部